Cancer biomarkers (CB) are biomolecules produced either by the tumor cells or by other cells of the body in response to the tumor. Every cell type has its unique molecular signature and identifiable characteristics such as levels or activities of myriad of genes, proteins, or other molecular features; therefore, biomarkers can facilitate the molecular definition of cancer.
Technologies Use:
- Imaging Technologies
- Omic Technologies
- Cytogenetic-Based Tests
- Immunoassays
A cancer biomarker is a substance or can be refereed to a process that helps to detect cancer in the human body. Cancer biomarkers are the biomolecules that help in diagnostic the cancerous cells and in turn decide to preventive measures. In other words, cancer biomarkers are the biological molecules produced either by tumour cells or by human tissues and in turn are extensively used in the detection and management of patients suffering from cancer. There are various types of biomarkers such as proteins, peptides, nucleic acids and so on. However, it must be noted that cancer biomarkers are the measuring devices and don’t indicate what the body feels or how the body functions.
For More Info: https://www.360marketupdates.com/enquiry/request-sample/22203362&piyush
Development and Mechanisms
Cancer is a multifactorial cluster of diseases reflecting fundamental abnormality involving uncontrolled cell growth and proliferation alternating the normal cell behavior. Molecular mechanisms exhibit alterations in the expression of multiple genes mostly includes: (proto) oncogenes, tumor suppressor genes, and DNA repair genes that contribute to the development of cancer genotype and phenotype with a state of dysregulation of cell proliferation events.
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Lung Cancer Biomarkers Market
• Overview of the regional outlook of the Lung Cancer Biomarkers Market: